What is Andreas Kyprianou's NPI number?

Andreas Kyprianou's National Provider Identifier (NPI) is 1639126105, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Andreas Kyprianou's specialty?

Andreas Kyprianou is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Andreas Kyprianou located?

Andreas Kyprianou's practice location on file with NPPES is 1345 W Bay Dr Ste 2-5, Largo, FL 33770-2282.

What is Andreas Kyprianou's phone number?

The practice phone number listed in the NPPES registry for Andreas Kyprianou is (727) 441-4526.

Does Andreas Kyprianou accept Medicare?

Andreas Kyprianou is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Andreas Kyprianou's NPI active?

Yes — Andreas Kyprianou's NPI (1639126105) is active in the NPPES registry as of the last update on 2021-08-11.

IndividualActiveAccepts Medicare

Andreas Kyprianou, MD

NPI 1639126105 · Pulmonary Disease Physician · Largo, FL

Andreas Kyprianou, MD is a Pulmonary Disease Physician provider in Largo, FL (NPI 1639126105).

Provider details

NPI number: 1639126105
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 2896 (AZ)

Practice location

1345 W Bay Dr Ste 2-5

Largo, FL 33770-2282

Phone: (727) 441-4526

Fax: (727) 266-4590

Street-level locationGet directions

More FL providers

Mailing address

5151 E Broadway Rd Ste 107

Mesa, AZ 85206-1346

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense 32610 (AZ)
Allopathic & Osteopathic Physicians
Pulmonary Disease Physician207RP1001XLicense 2896 (AZ)
Allopathic & Osteopathic Physicians
Sleep Medicine (Internal Medicine) Physician207RS0012XLicense 32610 (AZ)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(84/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,644 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	694	$116
Critical Care, First 30-74 Minutes99291	587	$209
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	102	$169
Critical Care, Each Additional 30 Minutes99292	62	$106
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	42	$176
Sleep Study Including Heart Rate, Breathing, Airflow, and Effort95806	41

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	35
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	32
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	25
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	18

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$396 across 8 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-05-28
Last updated: 2021-08-11
Certified: 2020-12-18

Frequently asked questions

What is Andreas Kyprianou's NPI number?: Andreas Kyprianou's National Provider Identifier (NPI) is 1639126105, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Andreas Kyprianou's specialty?: Andreas Kyprianou is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Andreas Kyprianou located?: Andreas Kyprianou's practice location on file with NPPES is 1345 W Bay Dr Ste 2-5, Largo, FL 33770-2282.
What is Andreas Kyprianou's phone number?: The practice phone number listed in the NPPES registry for Andreas Kyprianou is (727) 441-4526.
Does Andreas Kyprianou accept Medicare?: Andreas Kyprianou is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Andreas Kyprianou's NPI active?: Yes — Andreas Kyprianou's NPI (1639126105) is active in the NPPES registry as of the last update on 2021-08-11.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	694	$116
Critical Care, First 30-74 Minutes99291	587	$209
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	102	$169
Critical Care, Each Additional 30 Minutes99292	62	$106
Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215	42	$176
Sleep Study Including Heart Rate, Breathing, Airflow, and Effort95806	41

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	35
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	32
Budesonide/Glycopyr/Formoterolbrand: Breztri Aerosphere	25
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	18

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$396 across 8 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments